| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,773 | 1,726 | 2,424 | 1,695 | | Cost of Revenue | 925 | 1,160 | 1,142 | 1,332 | | | Gross Profit | 848 | 567 | 1,282 | 364 | | | Operating Expenses | | Research Development | 80 | 81 | 80 | 80 | | Selling General and Administrative | 685 | 1,245 | 1,242 | 1,543 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 83 | (759) | (40) | (1,259) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 83 | (759) | (40) | (1,259) | | Interest Expense | 30,428 | 29,452 | 486,203 | 228,934 | | Income Before Tax | (30,345) | (30,211) | (486,243) | (230,193) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (30,345) | (30,211) | (486,243) | (230,193) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (30,345) | (30,211) | (486,243) | (230,193) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($30,345) | ($30,211) | ($486,243) | ($230,193) |
|
0.52% Nasdaq 
Income Statement
